Esperion Therapeutics, Inc. (ESPR) SEC Filings — 2024

Filings

• Esperion Therapeutics Announces Material Definitive Agreement — 8-K · Dec 18, 2024
• Esperion Therapeutics Amends Credit Agreement with OrbiMed — 8-K · Dec 13, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Esperion Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
• Esperion Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• Esperion Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Oct 17, 2024
• Esperion Therapeutics Q2 Revenue Rises — 10-Q · Aug 12, 2024
• Esperion Therapeutics Appoints New Chief Medical Officer — 8-K · Aug 5, 2024
• Esperion Therapeutics Terminates Material Definitive Agreement — 8-K · Jun 28, 2024
• Esperion Therapeutics, Inc. SC 13G Filing — SC 13G · Jun 12, 2024
• Esperion Therapeutics Files 8-K: Director Changes & More — 8-K · May 28, 2024
• Esperion Therapeutics Files 8-K — 8-K · May 8, 2024
• Esperion Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
• Esperion Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 11, 2024
• Esperion Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Esperion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Wasatch Advisors LP Boosts Esperion Therapeutics Stake to 12.6% — SC 13G/A · Feb 9, 2024
• BB Biotech AG Maintains 4.19M Share Stake in Esperion Therapeutics — SC 13G/A · Jan 24, 2024
• Esperion Files 8-K on Material Agreement; Details Undisclosed — 8-K · Jan 22, 2024
• Esperion Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Jan 18, 2024
• Millennium Management Updates Esperion Therapeutics Stake — SC 13G/A · Jan 17, 2024
• Esperion Therapeutics Files 8-K, Confirms NASDAQ Listing — 8-K · Jan 11, 2024
• Meditor Group Discloses 3.3% Passive Stake in Esperion Therapeutics — SC 13G/A · Jan 3, 2024
• Esperion Therapeutics Files 8-K on Material Definitive Agreement — 8-K · Jan 3, 2024